Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Todos Medical Ltd (OP: TOMDF ) 0.0001 UNCHANGED Last Price Updated: 11:20 AM EDT, Sep 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Todos Medical Ltd < Previous 1 2 3 4 5 6 7 Next > Todos Medical to Present at The LD Micro Conference June 06, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Todos Medical Announces Enrollment Complete for Confirmatory Cohort of LymPro Alzheimer's Blood Test Clinical Validation Trial vs. Amyloid PET June 03, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Todos Medical Reports Day 26 Update For Case Study #4 June 01, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Todos Medical Releases Corporate Update May 27, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Todos Medical To Present At The Emerging Growth Conference April 25, 2022 - Wednesday, April 27, 2022 at 10:00am – 10:45am EST - Via Benzinga Todos Medical Appoints Philippe Goix As Chief Commercial Officer For Provista Diagnostics April 21, 2022 Strengthens Management Team and Positions the Company for Growth and Expansion Via Benzinga Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid® by LGC Group April 20, 2022 New York, NY, and Tel Aviv, ISRAEL – April 19, 2022 - Todos Medical, Ltd. Via Benzinga UPDATE: Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates April 04, 2022 New York, NY, and Tel Aviv, ISRAEL – April 1, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical to Present Final Data from the Tollovir Phase 2 Clinical Trial in Hospitalized COVID-19 Patients at the Personalized Medicine World Conference May 27, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Todos Medical Reports Day 14 Update from Ongoing 30-Day Case Study of Paxlovid Rebound Patient May 06, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength including 5 Day Dosing, 30 Day Dosing And 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim May 02, 2022 5-day and 30-day dosing regimen for 60-pill bottle allows for both support (5-day dosing) to reduce 3CL protease levels and to maintain (30-day dosing) low 3CL protease levels Via Benzinga Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Max Strength including 5 Day Dosing, 30 Day Dosing and 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim May 02, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures Product Safety Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates April 01, 2022 New York, NY, and Tel Aviv, ISRAEL – April 1, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Reports Case Study Of Patient With Long COVID March 31, 2022 New York, NY, and Tel Aviv, ISRAEL, March 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. Via Benzinga Billy Blanks® Endorses Todos Medical's Line Of Tollovid® Products March 28, 2022 New York, NY, and Tel Aviv, ISRAEL – March 27, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Initiates IRB-Waived Tollovid® Market Research Study And Announces 50% Price Reduction Until May 30th, 2022 April 27, 2022 New York, NY, and Tel Aviv, ISRAEL – April 27, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction until May 30th, 2022 April 27, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Todos Medical to Present at the Emerging Growth Conference April 25, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics April 21, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Todos Medical Reports 2nd Long COVID Case Study And Launches Website For Physicians And Pediatricians To Indicate Interest In Participating In Tollovid® Long COVID Clinical Study April 20, 2022 New York, NY, and Tel Aviv, ISRAEL – April 20, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study April 20, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid by LGC Group April 19, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire New Study Reportedly Calls Into Question Merck's Ivermectin COVID Off Label Use And May Bolster 3CL Protease Inhibitors Such As Tollovid April 12, 2022 Photo credit: Todos Medical This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid US FDA Certificate of Free Sale with Daily and Acute Dosing on the Label April 06, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Product Safety Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate Of Free Sale With Daily And Acute Dosing On The Label April 06, 2022 New York, NY, and Tel Aviv, ISRAEL – April 6, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned... Via Benzinga Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants April 04, 2022 New York, NY, and Tel Aviv, ISRAEL – April 4, 2022 - Todos Medical, Ltd. Via Benzinga Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants April 04, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire UPDATE: Todos Medical Reports Fourth-Quarter and Full-Year 2021 Financial Results and Corporate Updates April 01, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Todos Medical Reports Fourth-Quarter and Full-Year 2021 Financial Results and Corporate Updates April 01, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 Todos Medical Reports Case Study of Patient with Long COVID March 31, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
